Indiana Secures $4.3 Million Settlement with Pharmaceutical Distributor Over Opioid Addiction Medication

Attorney General Todd Rokita announced today that Indiana has entered into a $4.3 million settlement resolving allegations that pharmaceutical distributor Indivior improperly marketed and sold the drug Suboxone, a drug approved for use by recovering opioid addicts.

The company’s fraudulent statements and aggressive marketing tactics resulted in improper expenditures of Medicaid funds, according to allegations leveled in six whistleblower lawsuits.

“Indivior’s actions potentially harmed vulnerable Hoosiers and helped sustain drug addiction in this country at the very time they claimed to be helping eradicate it,” Attorney General Rokita said. “Even worse, they used ill-gotten Medicaid funds in the process — diverting resources from a program intended to help provide legitimate medical care to lower-income patients who truly need it.” 

Read the source article at wbiw.com